Overactive Bladder Treatment Market Worth 4.19 Billion USD by 2022

Overactive Bladder Treatment Market

According to a new market research report “Overactive Bladder Treatment Market by Pharmacotherapy (Anticholinergic- Solifenacin, Oxybutynin, Fesoterodine, Darifenacin; Mirabegron; BOTOX; Neurostimulation), Disease Type (Idiopathic and Neurogenic Bladder Overactivity) – Global Forecast to 2022” published by MarketsandMarkets™, the market is expected to reach USD 4.19 Billion by 2022 …

Overactive Bladder Treatment Market Global Forecast to 2022

The global overactive bladder treatment market is projected to reach USD 4.19 billion by 2022 from USD 3.63 billion in 2017, at a CAGR of 2.9%. Factors such as the development of innovative intravesical therapies, aggressive marketing by pharma companies leading to rising awareness on …